
Sign up to save your podcasts
Or


BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Barron's4.7
15081,508 ratings
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit megaphone.fm/adchoices

3,229 Listeners

1,728 Listeners

534 Listeners

985 Listeners

4,383 Listeners

2,189 Listeners

682 Listeners

1,037 Listeners

378 Listeners

212 Listeners

924 Listeners

1,313 Listeners

113 Listeners

211 Listeners

73 Listeners

85 Listeners

149 Listeners

20 Listeners

47 Listeners